Liang M, Zhang L, Gong H, Yang L, Wang H, Song N
Nucleic Acids Res. 2025; 53(5).
PMID: 40042815
PMC: 11880805.
DOI: 10.1093/nar/gkaf142.
Guigal-Stephan N, Lockhart B, Moser T, Heitzer E
J Exp Clin Cancer Res. 2025; 44(1):79.
PMID: 40022112
PMC: 11871688.
DOI: 10.1186/s13046-025-03328-4.
Dharmadhikari A, Abad M, Khan S, Maroofian R, Sands T, Ullah F
Nat Commun. 2025; 16(1):1703.
PMID: 39962046
PMC: 11833075.
DOI: 10.1038/s41467-025-56876-w.
Bokenkamp J, Keuper K, Redel S, Barthel K, Johnson L, Becker A
EMBO J. 2025; .
PMID: 39930267
DOI: 10.1038/s44318-025-00372-w.
Josephides J, Chen C
Nat Commun. 2025; 16(1):1472.
PMID: 39922809
PMC: 11807193.
DOI: 10.1038/s41467-025-56783-0.
Density estimation for ordinal biological sequences and its applications.
Chen W, Zhou J, McCandlish D
Phys Rev E. 2024; 110(4-1):044408.
PMID: 39562961
PMC: 11605730.
DOI: 10.1103/PhysRevE.110.044408.
High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.
Rymuza J, Kober P, Maksymowicz M, Nyc A, Mossakowska B, Woroniecka R
J Transl Med. 2024; 22(1):994.
PMID: 39497133
PMC: 11536836.
DOI: 10.1186/s12967-024-05736-0.
MAD1 upregulation sensitizes to inflammation-mediated tumor formation.
Copeland S, Snow S, Wan J, Matkowskyj K, Halberg R, Weaver B
PLoS Genet. 2024; 20(10):e1011437.
PMID: 39374311
PMC: 11486420.
DOI: 10.1371/journal.pgen.1011437.
Aneuploidy as a driver of human cancer.
Sdeor E, Okada H, Saad R, Ben-Yishay T, Ben-David U
Nat Genet. 2024; 56(10):2014-2026.
PMID: 39358600
DOI: 10.1038/s41588-024-01916-2.
Reduction of chromosomal instability and inflammation is a common aspect of adaptation to aneuploidy.
Hintzen D, Schubert M, Soto M, Medema R, Raaijmakers J
EMBO Rep. 2024; 25(11):5169-5193.
PMID: 39294502
PMC: 11549362.
DOI: 10.1038/s44319-024-00252-0.
Recent insights into the causes and consequences of chromosome mis-segregation.
Devillers R, Dos Santos A, Destombes Q, Laplante M, Elowe S
Oncogene. 2024; 43(43):3139-3150.
PMID: 39278989
DOI: 10.1038/s41388-024-03163-5.
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage.
Zerbib J, Ippolito M, Eliezer Y, De Feudis G, Reuveni E, Savir Kadmon A
Nat Commun. 2024; 15(1):7772.
PMID: 39251587
PMC: 11385192.
DOI: 10.1038/s41467-024-52176-x.
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer.
Gu Y, Sun M, Fang H, Shao F, Lin C, Liu H
Br J Cancer. 2024; 131(8):1320-1327.
PMID: 39217196
PMC: 11473753.
DOI: 10.1038/s41416-024-02825-1.
Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancer.
Spurr L, Pitroda S
Sci Rep. 2024; 14(1):19375.
PMID: 39169079
PMC: 11339421.
DOI: 10.1038/s41598-024-66062-5.
Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells.
Clairmont C, Gell J, Lau C
Cancer Control. 2024; 31:10732748241270564.
PMID: 39118322
PMC: 11311176.
DOI: 10.1177/10732748241270564.
Inference of chromosome selection parameters and missegregation rate in cancer from DNA-sequencing data.
Xiang Z, Liu Z, Dinh K
Sci Rep. 2024; 14(1):17699.
PMID: 39085295
PMC: 11291923.
DOI: 10.1038/s41598-024-67842-9.
Simple aneuploidy evades p53 surveillance and promotes niche factor-independent growth in human intestinal organoids.
Johnson B, Liu A, Bi T, Dong Y, Li T, Zhou D
Mol Biol Cell. 2024; 35(8):br15.
PMID: 38985518
PMC: 11321050.
DOI: 10.1091/mbc.E24-04-0166.
Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer.
Lim J, Kim E, Song J, Ahn S
Oncol Rep. 2024; 52(2).
PMID: 38904203
PMC: 11223027.
DOI: 10.3892/or.2024.8760.
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.
CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer.
Tucker J, Carlsen C, Scribano C, Pattaswamy S, Burkard M, Weaver B
Cancer Res. 2024; 84(16):2674-2689.
PMID: 38832939
PMC: 11326998.
DOI: 10.1158/0008-5472.CAN-23-3332.